New Positions Created to Manage Dramatic Growth HORSHAM, Pa.; May 4, 2021 – Clinical Ink, a global clinical trial technology company, today announced the hiring […]
Clinical Ink Hires CCO Chris Crucitti, COO Brian Donahue, VP Bill Barrasso Read More...
HORSHAM, Pa.; April 20, 2021 – Clinical Ink, a global clinical trial technology company, today announced it has deployed an industry-leading 500 unique eCOA scales
Discover how Clinical ink is advancing Alzheimer’s research by supporting 16th concurrent clinical trials in 25 countries, involving over 9,000 patients.
WILMINGTON, N.C. (March 22, 2021) – PPD, Inc. (Nasdaq: PPD), a leading global contract research organization, and Clinical ink, a global clinical technology company, have
HORSHAM, Pa.; Dec. 10, 2020 – Clinical ink, a global clinical trial technology company, today announced five years of providing clients with decentralized and hybrid
HORSHAM, Pa.; Dec. 3, 2020 – Clinical ink, a global clinical trial technology company, today announced an investment from McKesson Ventures alongside its significantly enhanced electronic patient reported outcome (ePRO) module. Lunexis™ ePRO+ is part of a unified
Horsham, Pa.; Aug. 4, 2020 – Clinical ink, a global clinical trial technology company, today announced its acquisition by GI Partners, a leading private equity
Horsham, Pa.; June 2, 2020 – Clinical Ink, a global clinical trial technology company, has helped expedite the study of a treatment for cytokine storm,
Horsham, Pa.; April 29, 2020 – Clinical Ink, a global clinical trial technology company, has announced a wide-ranging Study Assurance Program to minimize financial impact
Horsham, Pa.; April 14, 2020 – Clinical Ink, a global clinical trial technology company, has made a commitment to donate several hundred mobile phones and tablets to
Clinical Ink Donates Mobile Devices to Aid in Mental Tele-Health Read More...
In late September, the EMA released an important qualification opinion in favor of using eSource direct data capture (DDC) in clinical trials. The EMA’s opinion
EMA Greenlights eSource DDC and References Clinical ink Read More...
Horsham, PA.; June 13, 2019 – Clinical Ink, a global clinical trial technology company that is transforming the clinical trial experience, is pleased to announce
Sales and Solutions
Direct 1.336.464.0697
Support
Toll-Free 1.800.301.5033
Direct 1.336.464.0697
Insert HTML text here.
Request more information, submit questions, set up a demonstration, and more.
